Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 21, 2014European Journal of Neurology

A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

TLTimothée LengletSorbonne UniversitéLLLucette LacomblezCentre National de la Recherche ScientifiqueJAJean‐Louis AbitbolInventiva (France)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lenglet et al. (2014) studied this question.

synapsesocial.com/papers/6a7de98fc2b228f3e18ca7bahttps://doi.org/10.1111/ene.12344
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preclinical and subclinical events in motor neuron disease.1988 · 69 citations
  2. 2El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis2000 · 5,501 citations